Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease.

Chung J, Radojcic V, Perkey E, Parnell TJ, Niknafs Y, Jin X, Friedman A, Labrecque N, Blazar BR, Brennan TV, Siebel CW, Maillard I.

J Immunol. 2019 Jul 15;203(2):557-568. doi: 10.4049/jimmunol.1900192. Epub 2019 Jun 10.

PMID:
31182480
2.

Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye.

Radojcic V, Luznik L.

J Clin Invest. 2019 May 6;130:2189-2191. doi: 10.1172/JCI128710. eCollection 2019 May 6.

3.

Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.

Radojcic V, Paz K, Chung J, Du J, Perkey ET, Flynn R, Ivcevic S, Zaiken M, Friedman A, Yan M, Pletneva MA, Sarantopoulos S, Siebel CW, Blazar BR, Maillard I.

Blood. 2018 Nov 15;132(20):2188-2200. doi: 10.1182/blood-2018-03-841155. Epub 2018 Sep 4.

PMID:
30181175
4.

Multifaceted Burden of Chronic Graft-versus-Host Disease.

Radojcic V, Lee CJ, Couriel DR.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1774-1775. doi: 10.1016/j.bbmt.2018.07.012. Epub 2018 Aug 9. No abstract available.

PMID:
30016655
5.

Notching up B-cell pathology in chronic GVHD.

Radojcic V, Luznik L.

Blood. 2017 Nov 9;130(19):2053-2054. doi: 10.1182/blood-2017-09-805366. No abstract available.

6.

Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands.

Chung J, Ebens CL, Perkey E, Radojcic V, Koch U, Scarpellino L, Tong A, Allen F, Wood S, Feng J, Friedman A, Granadier D, Tran IT, Chai Q, Onder L, Yan M, Reddy P, Blazar BR, Huang AY, Brennan TV, Bishop DK, Ludewig B, Siebel CW, Radtke F, Luther SA, Maillard I.

J Clin Invest. 2017 Apr 3;127(4):1574-1588. doi: 10.1172/JCI89535. Epub 2017 Mar 20.

7.

Notch Signaling and Alloreactivity.

Radojcic V, Maillard I.

Transplantation. 2016 Dec;100(12):2593-2600. Review.

8.

Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders.

Chiang MY, Radojcic V, Maillard I.

Curr Opin Hematol. 2016 Jul;23(4):362-70. doi: 10.1097/MOH.0000000000000254. Review.

9.

The role of extracorporeal photopheresis in chronic graft-versus-host disease.

Radojcic V, Pletneva MA, Couriel DR.

Transfus Apher Sci. 2015 Apr;52(2):157-61. doi: 10.1016/j.transci.2015.02.002. Epub 2015 Feb 11. Review.

PMID:
25716169
10.

Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.

Wood S, Feng J, Chung J, Radojcic V, Sandy-Sloat AR, Friedman A, Shelton A, Yan M, Siebel CW, Bishop DK, Maillard I.

J Immunol. 2015 Mar 15;194(6):2899-908. doi: 10.4049/jimmunol.1402034. Epub 2015 Feb 16.

11.

A jagged road to lymphoma aggressiveness.

Radojcic V, Maillard I.

Cancer Cell. 2014 Mar 17;25(3):261-3. doi: 10.1016/j.ccr.2014.03.001.

12.

Blockade of individual Notch ligands and receptors controls graft-versus-host disease.

Tran IT, Sandy AR, Carulli AJ, Ebens C, Chung J, Shan GT, Radojcic V, Friedman A, Gridley T, Shelton A, Reddy P, Samuelson LC, Yan M, Siebel CW, Maillard I.

J Clin Invest. 2013 Apr;123(4):1590-604.

13.

Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.

Durakovic N, Radojcic V, Boban A, Mrsic M, Sertic D, Serventi-Seiwerth R, Nemet D, Labar B.

Intern Med. 2011;50(9):1009-13. Epub 2011 May 1.

14.

Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.

Zhang Y, Sandy AR, Wang J, Radojcic V, Shan GT, Tran IT, Friedman A, Kato K, He S, Cui S, Hexner E, Frank DM, Emerson SG, Pear WS, Maillard I.

Blood. 2011 Jan 6;117(1):299-308. doi: 10.1182/blood-2010-03-271940. Epub 2010 Sep 24.

15.

STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.

Radojcic V, Pletneva MA, Yen HR, Ivcevic S, Panoskaltsis-Mortari A, Gilliam AC, Drake CG, Blazar BR, Luznik L.

J Immunol. 2010 Jan 15;184(2):764-74. doi: 10.4049/jimmunol.0903006. Epub 2009 Dec 7.

16.

IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity.

Pletneva M, Fan H, Park JJ, Radojcic V, Jie C, Yu Y, Chan C, Redwood A, Pardoll D, Housseau F.

Cancer Res. 2009 Aug 15;69(16):6607-14. doi: 10.1158/0008-5472.CAN-09-0508.

17.

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination.

Radojcic V, Bezak KB, Skarica M, Pletneva MA, Yoshimura K, Schulick RD, Luznik L.

Cancer Immunol Immunother. 2010 Jan;59(1):137-48. doi: 10.1007/s00262-009-0734-3. Epub 2009 Jul 10.

18.
19.

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Durakovic N, Radojcic V, Skarica M, Bezak KB, Powell JD, Fuchs EJ, Luznik L.

Blood. 2007 May 15;109(10):4564-74. Epub 2007 Jan 16.

20.
21.

Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77/globotriaosylceramide phenotype.

Gagro A, Toellner KM, Grafton G, Servis D, Branica S, Radojcić V, Kosor E, Hrabak M, Gordon J.

Eur J Immunol. 2003 Jul;33(7):1889-98.

22.

[Plague then and now--significance and diagnostic problems].

Radojcić V.

Srp Arh Celok Lek. 1985 Oct;113(10):901-8. Serbian. No abstract available.

PMID:
3914089
23.

[The role of normal flora of the respiratory tract in infections caused by beta-hemolytic group A Streptococci].

Milić B, Radojcić V, Guberinić-Srećković M.

Srp Arh Celok Lek. 1983 Jun;111(6):761-8. Serbian. No abstract available.

PMID:
6364383
24.

[A visit to the Center for Communicable Disease Control in Atlanta, USA in 1982. News in microbiology and epidemiology].

Radojcić V.

Srp Arh Celok Lek. 1983 Mar;111(3):387-95. Serbian. No abstract available.

PMID:
6318369
25.

[Streptococci, penicillin and organism resistance. Failure of penicillin treatment of streptococcal infections of the upper respiratory tract].

Milić V, Guberinić M, Marjanović A, Radojcić V, Bokan O.

Srp Arh Celok Lek. 1982 Nov;110(11):1349-60. Serbian. No abstract available.

PMID:
7185187
26.

[Non-agglutinating cholera vibrios (NAG)].

Radojcić V.

Srp Arh Celok Lek. 1982 Oct;110(10):1233-43. Serbian. No abstract available.

PMID:
7182934
27.

[Nongonococcal urethritis and other diseases transmitted by sexual contact].

Radojcić V.

Srp Arh Celok Lek. 1981 Nov;109(11):1554-7. Serbian. No abstract available.

PMID:
6896769
28.

[Present trends in cholera and changes in cholera vibrios].

Radojcić V.

Glas Srp Akad Nauka Med. 1981;(33):93-104. Serbian. No abstract available.

PMID:
6927240
29.

[Spheroplasts, sporogenic bacilli and alpha-hemolytic forms of beta-hemolytic group A streptococcus].

Radojcić VD.

Srp Arh Celok Lek. 1980 Jul-Aug;108(7-8):733-42. Serbian. No abstract available.

PMID:
7022689
30.

[Problems in the campaign against streptococcal infections].

Radojcić V.

Srp Arh Celok Lek. 1979 May;107(5):487-94. Serbian. No abstract available.

PMID:
538529
31.

[Choleric vibrios and their atypical forms].

Radojcić V.

Srp Arh Celok Lek. 1977 Jun;105(6):513-23. Serbian. No abstract available.

PMID:
607469
32.

[Cholera in Tanzania and East Africa].

Radojcić V, Tarimo E, Sweeney T.

Srp Arh Celok Lek. 1977 Mar-Apr;105(3-4):281-90. Serbian. No abstract available.

PMID:
929330
33.

Urinary tract pathogens and antibiotic sensitivity patterns in Dar es Salaam.

Willett WC, Radojcic V.

East Afr Med J. 1976 Dec;53(12):685-92. No abstract available.

PMID:
1024815
34.

Cholera El Tor vibrios and atypical forms isolated during the outbreak of cholera in Kenya in 1971.

Radojcic V.

East Afr Med J. 1973 Dec;50(12):696-704. No abstract available.

PMID:
4596164
35.

[Cholera. Epidemiology, bacteriology, diagnosis].

Radojcić V.

Srp Arh Celok Lek. 1967 Sep;95(9):835-44. Serbian. No abstract available.

PMID:
5599582
36.

[HEMOLYTIC STREPTOCOCCI, AUTOANTIBODIES AND RHEUMATIC FEVER].

RADOJCIC V.

Srp Arh Celok Lek. 1964 Oct;92:939-48. Undetermined Language. No abstract available.

PMID:
14294165
37.

[Immunological features of the rheumatic factor].

RADOJCIC V.

Srp Arh Celok Lek. 1962 Feb;90:173-80. Undetermined Language. No abstract available.

PMID:
14489777
38.

[Chorea minor and antistreptolysin reaction; studies on etiopathogenesis of chorea minor].

RADOJCIC B, RADOJCIC V.

Hig Cas Hig Mikrobiol Epidemiol Sanit Teh. 1958;10(2):151-5. Undetermined Language. No abstract available.

PMID:
13598366
39.

[Personal experiences with antistreptolysin test].

DELOVSKI D, RADOJCIC V, SECUJAC B.

Srp Arh Celok Lek. 1956 Nov;84(11):1281-90. Undetermined Language. No abstract available.

PMID:
13391311
40.

[Antistreptolysin titer in acute rheumatism].

RADOJCIC V.

Srp Arh Celok Lek. 1954 Nov;82(11):1428-36. Undetermined Language. No abstract available.

PMID:
14373204
41.
42.

[Bacterial flora of the stomach in patients with subacute bacterial endocarditis].

ANTIC R, RADOJCIC V.

Srp Arh Celok Lek. 1953 Apr;81(4):345-53. Undetermined Language. No abstract available.

PMID:
13089927
43.

[Peroral effect of isonicotinic acid hydrazide on experimental tuberculosis in guinea pigs].

DJURISIC M, RADOJCIC V, NESKOVIC P.

Srp Arh Celok Lek. 1953 Apr;81(4):325-34. Undetermined Language. No abstract available.

PMID:
13089925

Supplemental Content

Loading ...
Support Center